Thought leaders at U-CARS meeting to explore issues related to heart recovery and regeneration

For many years, the answer to that question was unequivocally "No." But as the University of Utah School of Medicine's annual Utah Cardiac Recovery Symposium (U-CARS) will explore on Jan. 12-13, advances in treating heart failure are giving physicians, surgeons and researchers reason to hope the deadly disease might one day be defeated.

Now in its fifth year, the one-of-a-kind conference has been described as a "think tank" where national leaders will convene for the unique two-day event aimed at advancing the field of heart recovery. Presenters and attendees include hundreds of cardiologists, surgeons, radiologists, anesthesiologists, ER physicians, nurses, pharmacists and research scientists, each contributing their unique perspective.

Heart failure is caused by a weakened heart that cannot pump blood effectively, and the need to find ways to better treat the condition has never been greater. In the United States alone, the number of people with heart failure is expected to increase from 5.7 million to almost 8 million by 2030. Half of all those who get heart failure die within five years of diagnosis, an outlook worse than that for most cancers.

The impending reality has prompted the U's heart recovery team, jointly led by Craig Selzman, M.D., cardiothoracic surgeon and U medical school professors Joseph Stehlik, M.D., M.P.H., and Stavros Drakos, M.D., Ph.D., to organize the yearly symposium.

"Our goal is to bring a group of health care providers and researchers together with the focused intent on understanding and implementing therapies to make a bad heart get better," he says. "The U-CARS meeting brings thought leaders from around the country and the globe to exchange ideas, debate paradigms and share information focused on issues related to heart recovery and regeneration."

Media are welcome to attend the keynote and any of the symposium's eight sessions, which will feature several speakers covering topics such as the practical application of precision medicine to heart failure, peripheral vascular function in heart failure and recovery, and salvaging heart tissue in cases of acute coronary syndrome ("heart attacks" or sudden loss of blood to the heart).

Symposium Highlights

Keynote address - Valentin Fuster, M.D., Ph.D: A world-renowned cardiologist, editor-in-chief of the Journal of the American College of Cardiology, and physician-in-chief of the Mount Sinai Hospital in New York City, Fuster has published more than 900 articles on coronary artery disease, atherosclerosis and thrombosis, and has received numerous awards in the United States and Europe for his research and teaching. His many research accomplishments include major discoveries involving the role of platelets in atherothrombotic disease and coronary artery bypass grafts, an important role of HDL in reversing lipid and macrophange plaques and many of aspects heart disease and failure.

Breaking Research - Mechanical Unloading and Recovery: the Utah Cardiac Recovery Program (UCAR) Approach (session 6): University of Utah investigators Frank Sachse, M.D., and Stavros Drakos, M.D., will present new data showing that specific changes in the microstructure of the heart muscle can predict recovery of cardiac function, providing new guidance on how to apply cardiac therapeutic interventions in day-to-day patient care.

Full descriptions are available on the U-CARS symposium website. Click on the agenda link on the upper left side of the page. Note that all times are listed as Mountain Standard Time. The symposium will be live streamed during the event: http://www.kaltura.com/tiny/guvl3

Source: University of Utah Health Sciences

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study reveals variability in polygenic risk scores for predicting heart disease